New Viagra gives family man the droop
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.For millions of impotent men around the globe, the announcement of a new Viagra-style wonder drug, called Cialis, is cause for rejoicing. But for Albert Cialis, a retired accountant from Kent, it's nothing short of a disaster.
Mr Cialis is convinced that while the new cure for impotence may be a boon for sexually frustrated men, its imminent arrival will destroy his and his family's credibility.
Now he is threatening legal action against Eli Lilly if it doesn't change the name of its drug.
"We are horrified at this situation. It is like being called the Viagra family," he told The Independent on Sunday.
"There is likely to be ridicule and worse, especially for young members of the family and a burden for our young children, who can expect to be teased at school with consequent psychological damage."
Eli Lilly, one of the world's largest pharmaceutical companies, explained that the name of its drug was a play on words, referring to the phrase "the sky's the limit" via ciel the French for "sky".
Mr Cialis has begun a campaign to get the decision overturned and last week went public with his concerns by contacting the British Medical Journal.
If he succeeds in getting the product renamed it will cost Eli Lilly, which has a reputation for treating schizophrenia, an estimated £1m in the UK alone to rebrand it in time for the launch next year.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments